BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 13 hours ago Valaris Limited Drops 6.7% in Broad Selloff 14 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 14 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 14 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 15 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 15 hours ago Celanese Corporation Shares Dropping 5.5% 15 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 15 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 15 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 15 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 13 hours ago Valaris Limited Drops 6.7% in Broad Selloff 14 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 14 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 14 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 15 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 15 hours ago Celanese Corporation Shares Dropping 5.5% 15 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 15 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 15 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 15 hours ago
ADVERTISEMENT
AlphaGraphs

MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024. The company reported a net income for Q1, compared to a loss last year. Trxade reported a net income of $21.25 million for the three months ended March 31, 2024, compared to a loss of […]

June 28, 2024 1 min read

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024. The company reported a net income for Q1, compared to a loss last year. Trxade reported a net income of $21.25 million for the three months ended March 31, 2024, compared to a loss of […]

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024. The company reported a net income for Q1, compared to a loss last year.

Trxade Q1 2024 earnings infographic

Trxade reported a net income of $21.25 million for the three months ended March 31, 2024, compared to a loss of $0.68 million in the corresponding period of the prior fiscal year. On a per-share basis, earnings were $16.77 per share in the first quarter, compared to a loss of $1.01 per share in the prior-year quarter.

Net income from discontinued operations, related to divestitures, was $27.88 million. The company did not generate any revenues during the quarter.

Prior Performance

  • Trxade FY23 earnings infographic
  • Trxade Q3 2023 earnings infographic
  • Trxade Q1 2024 earnings infographic

ADVERTISEMENT